Avandia

The diabetes drug Avandia (active ingredient rosiglitazone) has not been approved in this country since November 2010, as in several studies significant health risks were found in the intake. Given the cardiovascular risks and increased heart attacks, the European Medicines Agency had previously rated the benefit-risk balance of Avandia as unfavorable. Although health risks have not been confirmed in recent studies, Avandia is currently no longer in use in this country. (Fp)

Heart attack risk at Avandia Diabetes Center

Increased risk of heart attack in diabetes Agent: The European Medicines Agency EMA has suspended the approval of the diabetes drug Avandia. That for ...
More diabetes drug increases heart attack risk?

Diabetes drug increases heart attack risk? Will the Avandia drug be taken from the drug market in Germany as well? (08.09.2010)
More Diabetes Means Avandia Under Infarction Suspicion

Bad suspicion: Does the diabetes drug "Avandia" cause fatal heart disease? According to the online edition of the "New York Times & ...
More

(Photo 1: Kwangmoo / fotolia.com)